GFAP and Alzheimer disease: In addition, a higher abundance of Erysipelatoclostridium in the gut has been described to be associated with better cognitive function in APP/PS1 mice [28] and with lower serum levels of phosphorylated tau (pTau)181 and glial fibrillary acidic protein (GFAP) in human AD patients [29].